3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Neoplasms
6
Breast Neoplasms
4
Prostatic Neoplasms
3
Lung Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Parkinson Disease
1
Osteosarcoma
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Histologically-confirmed Malignancies
1
Hepatic Malignancies
1
Hematologic Neoplasms
1
Glioma
1
Glioblastoma
1
Febrile Neutropenia
1
Esophageal Neoplasms
1
Carcinoma, Neuroendocrine
1
Carcinoma, Hepatocellular
1
Interventions
Cytarabine
19
Cyclophosphamide
18
venetoclax
15
fludarabine phosphate
14
Busulfan
14
Cyclosporine
12
Azacitidine
11
fludarabine
10
Peripheral Blood Stem Cell Transplantation
10
Granulocyte Colony-Stimulating Factor
10
Mycophenolic Acid
9
Filgrastim
9
Melphalan
8
Antilymphocyte Serum
8
Whole-Body Irradiation
7
Palliative Care
7
Idarubicin
6
Blood Specimen Collection
6
Methotrexate
5
Therapeutics
4
Specimen Handling
4
Radiotherapy
4
Methods
4
Early Intervention, Educational
4
Daunorubicin
4
Cord Blood Stem Cell Transplantation
4
thymoglobulin
3
Thiotepa
3
Tacrolimus
3
Psychiatric Rehabilitation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia, Myeloid, Acute
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT03429387
2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA
Completed
147 enrolled